FLEDGE Members enjoy a supportive, collaborative working environment with access to prototyping facilities, regular mentoring sessions, and an extensive MedTech network.
Oncosil Medical Limited (ASX : OSL)
An active implantable brachytherapy system for cancer treatment, based on Phosphorous-32 Microparticles injected into a tumour using endoscopic ultrasound guidance.
Providing intuitive and user-focussed products that help create incredibly immersive Virtual Reality experiences.
A cost-effective smart factory platform that reduces manufacturing risk, and maximises workflow effectiveness, particularly for regulated industries such as medical devices.
Medulla graduated from Fledge in January 2018.
Respiration Enhancement & Support for Preterm Infants
Reducing the mortality rate of preterm infants born in resource-limited countries.
Building non-contact VR interfaces and VR content for people living with cerebral palsy, acquired brain injury, spinal cord injury, stroke and neuro-muscular disorders.
FLEDGE Fund investments
- NSW = $225,000
- Federal = $500,000